150 related articles for article (PubMed ID: 35354962)
21. IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.
Yu J; Ming H; Li HY; Yu B; Chu M; Zhu H; Zhu X
Toxicol Appl Pharmacol; 2019 Oct; 381():114732. PubMed ID: 31454633
[TBL] [Abstract][Full Text] [Related]
22. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
[TBL] [Abstract][Full Text] [Related]
24. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway.
Chen B; Li J; Zhu H
Vascul Pharmacol; 2016 Oct; 85():1-10. PubMed ID: 26297684
[TBL] [Abstract][Full Text] [Related]
25. IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.
Shi H; Wang Q; Yang L; Xie S; Zhu H
FEBS Open Bio; 2017 Sep; 7(9):1379-1391. PubMed ID: 28904866
[TBL] [Abstract][Full Text] [Related]
26. Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells.
Li XQ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Liu LX
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):395-404. PubMed ID: 28823370
[TBL] [Abstract][Full Text] [Related]
27. The aqueous extract of Gentianella acuta improves isoproterenol‑induced myocardial fibrosis via inhibition of the TGF‑β1/Smads signaling pathway.
Yang HX; Xu GR; Zhang C; Sun JH; Zhang Y; Song JN; Li YF; Liu Y; Li AY
Int J Mol Med; 2020 Jan; 45(1):223-233. PubMed ID: 31939619
[TBL] [Abstract][Full Text] [Related]
28. Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway.
Elsayed M; Moustafa YM; Mehanna ET; Elrayess RA; El-Sayed NM; Hazem RM
Life Sci; 2024 Jan; 337():122354. PubMed ID: 38110076
[TBL] [Abstract][Full Text] [Related]
29. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways.
Chen G; Xu H; Xu T; Ding W; Zhang G; Hua Y; Wu Y; Han X; Xie L; Liu B; Zhou Y
Phytomedicine; 2022 Sep; 104():154277. PubMed ID: 35752078
[TBL] [Abstract][Full Text] [Related]
30. Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent.
Ma X; Fu Y; Xiao H; Song Y; Chen R; Shen J; An X; Shen Q; Li Z; Zhang Y
PLoS One; 2015; 10(6):e0129971. PubMed ID: 26068068
[TBL] [Abstract][Full Text] [Related]
31. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
32. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
33. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8087-8094. PubMed ID: 31599435
[TBL] [Abstract][Full Text] [Related]
34. Beneficial Metabolic Effects of 2',3',5'-Triacetyl-N
Li T; Sun S; Zhang J; Qu K; Yang L; Ma C; Jin X; Zhu H; Wang Y
J Proteome Res; 2018 Aug; 17(8):2870-2879. PubMed ID: 29925242
[TBL] [Abstract][Full Text] [Related]
35. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
36. Sodium houttuyfonate against cardiac fibrosis attenuates isoproterenol-induced heart failure by binding to MMP2 and p38.
Tan R; You Q; Cui J; Wang M; Song N; An K; Lin L; Adu-Amankwaah J; Yuan J; Sun H
Phytomedicine; 2023 Jan; 109():154590. PubMed ID: 36610170
[TBL] [Abstract][Full Text] [Related]
37. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
[TBL] [Abstract][Full Text] [Related]
38. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
Tan QY; Cheng ZS
Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
[TBL] [Abstract][Full Text] [Related]
39. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation.
Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Sato M; Doi H; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1384-90. PubMed ID: 15217807
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.
Sun J; Wang Z; Shi H; Gu L; Wang S; Wang H; Li Y; Wei T; Wang Q; Wang L
Biochem Biophys Res Commun; 2020 Jan; 521(3):814-820. PubMed ID: 31708099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
